PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics
PhaseBio Pharmaceuticals, Inc. (PHAS)
Today's Latest Price: $4.06 USD
Updated Jan 27 9:00am
Add PHAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PHAS Stock Price Chart Interactive Chart >
PHAS Price/Volume Stats
| Current price | $4.06 | 52-week high | $6.85 |
| Prev. close | $4.12 | 52-week low | $2.60 |
| Day low | $4.06 | Volume | 222 |
| Day high | $4.06 | Avg. volume | 299,013 |
| 50-day MA | $3.90 | Dividend yield | N/A |
| 200-day MA | $4.05 | Market Cap | 119.22M |
PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio
PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
Loading social stream, please wait...